Elevated Levels of miR-144-3p Induce Cholinergic Degeneration by Impairing the Maturation of NGF in Alzheimer’s Disease
Cholinergic degeneration is one of the key pathological hallmarks of Alzheimer’s disease (AD), a condition that is characterized by synaptic disorders and memory impairments. Nerve growth factor (NGF) is secreted in brain regions that receive projections from the basal forebrain cholinergic neurons....
Main Authors: | Lan-Ting Zhou, Juan Zhang, Lu Tan, He-Zhou Huang, Yang Zhou, Zhi-Qiang Liu, Youming Lu, Ling-Qiang Zhu, Chengye Yao, Dan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.667412/full |
Similar Items
-
hNGF Peptides Elicit the NGF-TrkA Signalling Pathway in Cholinergic Neurons and Retain Full Neurotrophic Activity in the DRG Assay
by: Viviana Triaca, et al.
Published: (2020-02-01) -
Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF
by: Sumonto Mitra, et al.
Published: (2019-02-01) -
Characterization of the transcripts of human cytomegalovirus UL144
by: Sun Zhengrong, et al.
Published: (2011-06-01) -
Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease
by: M. Florencia Iulita, et al.
Published: (2017-12-01) -
NGF and therapeutic prospective: what have we learned from the NGF transgenic models?
by: Luigi Aloe, et al.
Published: (2015-03-01)